Phil Franchina, Author at American Parkinson Disease Association

APDA’S SPANISH-LANGUAGE RESOURCES

Posted on March 10, 2022 by Phil Franchina

The American Parkinson Disease Association (APDA) works tirelessly to support the Parkinson’s disease (PD) community,...see more but we know we are not reaching everyone. We are dedicated to finding ways to broaden our reach and meet the needs of underserved, under-resourced, and rural communities. One way we’re working toward this is with […]

APRIL IS PARKINSON’S DISEASE AWARENESS MONTH

Posted on March 10, 2022 by Phil Franchina

There’s never been a better time to show up and show your...see more support for the Parkinson’s disease (PD) community — April is PD Awareness Month! We’re uniting forces from coast to coast to raise awareness, raise funds, and raise hope for individuals and families affected by PD. And […]

TAKING RESEARCH FROM THE LAB TO OUR LIVES

Posted on March 10, 2022 by Phil Franchina

Sometimes, it is difficult to understand how Parkinson’s disease (PD)...see more research that is being done now in a lab will benefit people with PD in “real life.” In a recent episode of our popular online program, Dr. Gilbert Hosts, we sat down with two researchers funded […]

HOPE AND YOUNG ONSET PARKINSON’S DISEASE

Posted on March 10, 2022 by Phil Franchina

When you envision someone living with Parkinson’s disease, what comes to mind? Are...see more they a rock climber? An American Ninja Warrior? A nurse? Or perhaps the parent of a young child? Probably not. What you might be surprised to learn is that people with Parkinson’s disease (PD) defy expectations […]

Dhivy^TM, a carbidopa/levodopa fractionated tablet, is now available

Posted on March 9, 2022 by Phil Franchina

A new formulation of carbidopa/levodopa 25/100, called DhivyTM, is now available. Manufactured by Avion Pharmaceuticals, its innovation is that...see more it is scored into four sections allowing the pill to be easily cut into four equal parts. Each part contains 6.25 mg of carbidopa and 25 mg of levodopa. The medication was approved by the US […]

“ASK THE DOCTOR” with Dr. Rebecca Gilbert

Posted on December 31, 2021 by Phil Franchina

Q. I am in my late 80s, and I think I...see more have Parkinson’s disease. At my age, should I bother going to a neurologist to see if I actually have PD? Yes! If you do have PD, there may be medications that you can take to allow […]

WHAT COGNITIVE CHANGES CAN MEAN FOR SOMEONE LIVING WITH PD

Posted on December 31, 2021 by Phil Franchina

As many as 20-50% of individuals with Parkinson’s...see more disease (PD) are also living with mild cognitive impairment (MCI) — but what exactly does that mean? MCI is an early stage of cognitive difficulty that does not interfere with a person’s usual capacity to perform […]

HOLE IN ONE! TAKING A SWING FOR THE PD COMMUNITY

Posted on December 31, 2021 by Phil Franchina

That’s no bogey for Joseph “Jay” Scott ―...see more he’s scoring on par for the PD community! Jay (shown above, on the right) took to the green this summer to raise funds for APDA by playing seven golf courses in seven states — all in […]

JUST AROUND THE CORNER: THE BRIGHT HORIZON OF PD RESEARCH

Posted on December 31, 2021April 19, 2024 by Phil Franchina

The scientists, researchers, and clinicians in the Parkinson’s disease...see more (PD) research community, including many researchers funded by the American Parkinson Disease Association (APDA), are approaching the search for a cure from all directions. A treatment that is neuroprotective — meaning that it protects the brain’s […]

APDA funding is critical to new research in understanding Levodopa-induced dyskinesias

Posted on September 22, 2021 by Phil Franchina

In an exciting new study, researchers at the Graduate Center, City University of New York (CUNY) and the CUNY...see more School of Medicine, led by Dr. Andreas Kottmann, studied levodopa induced dyskinesias (LIDs) and demonstrated that inhibiting a protein called sonic hedgehog (Shh) decreased LIDs in animal models of PD. The study appears today in Communications […]

What is Parkinson’s Disease?

Living with Parkinson’s Disease

Parkinson’s Resource Library

Research

APDA’S SPANISH-LANGUAGE RESOURCES

APRIL IS PARKINSON’S DISEASE AWARENESS MONTH

TAKING RESEARCH FROM THE LAB TO OUR LIVES

HOPE AND YOUNG ONSET PARKINSON’S DISEASE

Dhivy^TM, a carbidopa/levodopa fractionated tablet, is now available

“ASK THE DOCTOR” with Dr. Rebecca Gilbert

WHAT COGNITIVE CHANGES CAN MEAN FOR SOMEONE LIVING WITH PD

HOLE IN ONE! TAKING A SWING FOR THE PD COMMUNITY

JUST AROUND THE CORNER: THE BRIGHT HORIZON OF PD RESEARCH

APDA funding is critical to new research in understanding Levodopa-induced dyskinesias

Support Our Mission

Support Our Mission

Subscribe to get updates from APDA and helpful Parkinson’s info!